Tica and Enoxa

Ticagrelor is a ______receptor antagonist and leads to platelet aggregation.

• Thromboxane A2

• PAR 1

• PAR 2

• P2Y12

State true or False: Enoxaparin is a direct factor IIa and Xa inhibitor.

• True

• False

5 bevel needle point geometry of LMWX leads to

• Lesser pain to patient

• Lesser force in injecting medicine

• Both a and b

Plato trial is a direct comparison between Ticagrelor and _______

• Aspirin

• Prasugrel

• Clopidogrel

• None of these

State True or False: Aspirin is a P2Y12 receptor antagonist.

• True

• False

On set of action of Ticagrelor begins at

• 1 hour

• 2 hours

• 30 minutes

• 45 minutes

Duration of effect of Ticagrelor remains for

• 5 to 10 days

• 3 to 4 days

• 3 to 10 days

• None of these

•According to the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy (DAPT) at least___ months in patients with ACS

• 3

• 6

• 9

• 12

•Initiate treatment with ____ mg oral loading dose following an ACS event. Continue treatment with ___mg twice daily during the first year after an ACS event. After one year, administer ____ mg twice daily.

• 60, 90, 180

• 90, 180, 60

• 180, 90, 60

• None of these

In Acute Ischemic Stroke, Initiate treatment with a _____ mg loading dose of Ticagrelor then continue with ____ mg twice daily for up to 30 days.

• 90, 180

• 180, 90

• 60, 90

• 60, 180